基础医学与临床 ›› 2026, Vol. 46 ›› Issue (4): 524-530.doi: 10.16352/j.issn.1001-6325.2026.04.0524

• 研究论文 • 上一篇    下一篇

成纤维细胞生长因子受体1杂合缺失损伤小鼠精子活力

李晨阳1, 李婷1, 王曦1, 聂敏1, 伍学焱1, 茅江峰1*, 韩钦2*   

  1. 1.中国医学科学院北京协和医学院 北京协和医院 内分泌科,北京 100730;
    2.中国医学科学院北京协和医学院 基础医学研究所 组织工程中心 人工智能细胞医药工程技术交叉创新与临床转化北京市重点实验室,北京 100005
  • 收稿日期:2025-04-18 修回日期:2025-07-14 发布日期:2026-03-24
  • 通讯作者: *maojf@pumch.cn;hanqin@ibms.pumc.edu.cn
  • 基金资助:
    北京市自然科学基金(7212080)

Impairment of sperm motility in mice with heterozygous deletion of fibroblast growth factor receptor 1

LI Chenyang1, LI Ting1, WANG Xi1, NIE Min1, WU Xueyan1, MAO Jiangfeng1*, HAN Qin2*   

  1. 1. Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730;
    2. Center for Excellence in Tissue Engineering, Beijing Key Laboratory of Artificial Intelligence and Cell-based Medical Engineering for Interdisciplinary Innovation and Clinical Translation, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
  • Received:2025-04-18 Revised:2025-07-14 Published:2026-03-24
  • Contact: *maojf@pumch.cn;hanqin@ibms.pumc.edu.cn

摘要: 目的 探究先天性低促性腺激素性性腺功能减退症(CHH)中成纤维细胞生长因子受体1(FGFR1)杂合缺失对生殖功能的作用。方法 构建FGFR1杂合敲除小鼠模型(FGFR1+/-),运用聚合酶链反应(PCR)与Sanger测序方法进行分析,验证目标外显子的敲除情况。采用免疫组化与 Western blot,对蛋白表达进行检测。对小鼠的生殖能力、生殖功能(精子浓度、活力、前进性)展开测定,测量小鼠的 BMI、睾丸质量、睾丸体积,以及各类性激素水平(包括 T、E2、AMH、FSH、LH和INH - B),并进行统计学分析。结果 研究构建了FGFR1杂合敲除的小鼠模型,PCR测序结果显示小鼠FGFR1外显子4、5被成功敲除,Western blot与免疫组化结果显示FGFR1蛋白表达减少。与野生型(WT)相比,FGFR1+/-小鼠的精子活力更差(P<0.001),前进精子数量更少 (P<0.01)。与WT小鼠相比,FGFR1+/-小鼠的INH-B水平略有升高(P<0.05)。结论 FGFR1杂合缺失影响小鼠精子活力,为深入探究先天性低促性腺激素性性腺功能减退症生殖功能障碍的发病机制提供了关键依据。

关键词: 成纤维细胞生长因子受体1, 精子发生, 睾丸发育, 先天性低促性腺激素性性腺功能减退症

Abstract: Objective To investigate the effect of heterozygous deletion of fibroblast growth factor receptor 1 (FGFR1) on reproductive function in congenital hypogonadotropic hypogonadism (CHH). Methods A heterozygous FGFR1 knockout mouse model (FGFR1+/-) was established. Polymerase chain reaction (PCR) and Sanger sequencing were performed to confirm the deletion of the target exons. Immunohistochemistry and Western blot were used to detect FGFR1 protein expression. Reproductive capacity and function (including sperm concentration, motility, and progressive motility) were evaluated. Additionally, body mass index (BMI), testicular weight, testicular volume, and various sex hormone levels (including T, E2, AMH, FSH, LH, and INH-B) were measured and analyzed statistically. Results The FGFR1 heterozygous knockout mouse model was successfully constructed. PCR and sequencing results confirmed the deletion of exons 4 and 5 of the FGFR1 gene. Western blot and immunohistochemistry demonstrated reduced FGFR1 protein expression. Compared with wild-type (WT) mice, FGFR1+/- mice exhibited significantly lower sperm motility(P<0.001) and fewer progressively motile sperm (P<0.01). Compared with WT mice, the INH-B level in FGFR1+/- mice was slightly elevated (P<0.05). Conclusions Heterozygous deletion of FGFR1 impairs sperm motility in mice, providing critical evidence for further elucidating the pathogenesis of reproductive dysfunction in congenital hypogonadotropic hypogonadism.

Key words: fibroblast growth factor receptor 1(FGFR1), spermatogenesis, testicular development, congenital hypogonadotropic hypogonadism (CHH)

中图分类号: